Compare Pelayaran Jaya Hidup Baru Tbk. (PJHB) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pelayaran Jaya Hidup Baru Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Pelayaran Jaya Hidup Baru Tbk. trades at Rp181 (market cap 351.55B, 1.7M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Pelayaran Jaya Hidup Baru Tbk. is far larger — about 3.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PJHB | SCPI | |
|---|---|---|
Market Cap | 351.55B | 104.4B |
Volume | 1.7M | — |
Lot | 17.03K | — |
Turnover | 306.54M | — |
Average Price | 179.99 | — |
Value | 306.54M | — |
Indicative Equilibrium Price | 181 | — |
Indicative Equilibrium Volume | 517 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pelayaran Jaya Hidup Baru Tbk.
PT. Pelayaran Jaya Hidup Baru Tbk. hereinafter referred to as the Company, was established under the name PT. Pelayaran Dalam Negeri Jaya Hidup Baru in Surabaya based on the Deed of Notary Susanto Tjiptowidjojo, S.H., Number 3 dated October 9, 2008. The Company controlling shareholder is Hero Gozali.
Read more on PJHB →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
